StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$96.32−2.92 (-2.94%)

Close on Nov 17, 2026Market cap $6.38BP/E –Yield –

Oruka Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Oruka Therapeutics's EV/EBITDA was 0.7× on Oct 31, 2011.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2011Oct 31, 20110.7×–

More Oruka Therapeutics figures

See a number that looks wrong?